Medical - Devices
Compare Stocks
2 / 10Stock Comparison
XAIR vs AVPT
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
XAIR vs AVPT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Software - Infrastructure |
| Market Cap | $4M | $2.23B |
| Revenue (TTM) | $7M | $444M |
| Net Income (TTM) | $-31M | $47M |
| Gross Margin | 1.8% | 73.7% |
| Operating Margin | -419.5% | 9.6% |
| Forward P/E | — | 27.7x |
| Total Debt | $12M | $10M |
| Cash & Equiv. | $5M | $481M |
XAIR vs AVPT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | 100 | 0.3 | -99.7% |
| AvePoint, Inc. (AVPT) | 100 | 105.4 | +5.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: XAIR vs AVPT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
XAIR is the clearest fit if your priority is income & stability and growth exposure.
- beta 0.47
- Rev growth 219.7%, EPS growth 62.1%
- Lower volatility, beta 0.47, Low D/E 81.5%, current ratio 3.20x
AVPT carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 5.5% 10Y total return vs XAIR's -99.6%
- 10.5% margin vs XAIR's -447.7%
- -40.0% vs XAIR's -86.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 219.7% revenue growth vs AVPT's 26.9% | |
| Quality / Margins | 10.5% margin vs XAIR's -447.7% | |
| Stability / Safety | Beta 0.47 vs AVPT's 1.06 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -40.0% vs XAIR's -86.2% | |
| Efficiency (ROA) | 6.3% ROA vs XAIR's -84.3%, ROIC 11.4% vs -121.4% |
XAIR vs AVPT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
XAIR vs AVPT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AVPT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVPT is the larger business by revenue, generating $444M annually — 64.1x XAIR's $7M. AVPT is the more profitable business, keeping 10.5% of every revenue dollar as net income compared to XAIR's -4.5%. On growth, XAIR holds the edge at +104.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $7M | $444M |
| EBITDAEarnings before interest/tax | -$25M | $47M |
| Net IncomeAfter-tax profit | -$31M | $47M |
| Free Cash FlowCash after capex | -$22M | $105M |
| Gross MarginGross profit ÷ Revenue | +1.8% | +73.7% |
| Operating MarginEBIT ÷ Revenue | -4.2% | +9.6% |
| Net MarginNet income ÷ Revenue | -4.5% | +10.5% |
| FCF MarginFCF ÷ Revenue | -3.2% | +23.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +104.7% | +26.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +71.3% | +3.6% |
Valuation Metrics
XAIR leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $4M | $2.2B |
| Enterprise ValueMkt cap + debt − cash | $11M | $1.8B |
| Trailing P/EPrice ÷ TTM EPS | -0.04x | 68.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 27.75x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 44.79x |
| Price / SalesMarket cap ÷ Revenue | 1.13x | 5.31x |
| Price / BookPrice ÷ Book value/share | 0.12x | 4.94x |
| Price / FCFMarket cap ÷ FCF | — | 27.32x |
Profitability & Efficiency
AVPT leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
AVPT delivers a 10.2% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-4 for XAIR. AVPT carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to XAIR's 0.82x. On the Piotroski fundamental quality scale (0–9), AVPT scores 6/9 vs XAIR's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -3.7% | +10.2% |
| ROA (TTM)Return on assets | -84.3% | +6.3% |
| ROICReturn on invested capital | -121.4% | +11.4% |
| ROCEReturn on capital employed | -126.4% | +8.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.82x | 0.02x |
| Net DebtTotal debt minus cash | $7M | -$471M |
| Cash & Equiv.Liquid assets | $5M | $481M |
| Total DebtShort + long-term debt | $12M | $10M |
| Interest CoverageEBIT ÷ Interest expense | -10.24x | — |
Total Returns (Dividends Reinvested)
AVPT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVPT five years ago would be worth $10,168 today (with dividends reinvested), compared to $48 for XAIR. Over the past 12 months, AVPT leads with a -40.0% total return vs XAIR's -86.2%. The 3-year compound annual growth rate (CAGR) favors AVPT at 32.6% vs XAIR's -83.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -37.0% | -21.9% |
| 1-Year ReturnPast 12 months | -86.2% | -40.0% |
| 3-Year ReturnCumulative with dividends | -99.6% | +133.0% |
| 5-Year ReturnCumulative with dividends | -99.5% | +1.7% |
| 10-Year ReturnCumulative with dividends | -99.6% | +5.5% |
| CAGR (3Y)Annualised 3-year return | -83.5% | +32.6% |
Risk & Volatility
Evenly matched — XAIR and AVPT each lead in 1 of 2 comparable metrics.
Risk & Volatility
XAIR is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than AVPT's 1.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AVPT currently trades 51.0% from its 52-week high vs XAIR's 8.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.47x | 1.06x |
| 52-Week HighHighest price in past year | $5.84 | $20.25 |
| 52-Week LowLowest price in past year | $0.43 | $8.83 |
| % of 52W HighCurrent price vs 52-week peak | +8.5% | +51.0% |
| RSI (14)Momentum oscillator 0–100 | 45.0 | 54.1 |
| Avg Volume (50D)Average daily shares traded | 254K | 1.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $17.50 |
| # AnalystsCovering analysts | — | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.2% |
AVPT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). XAIR leads in 1 (Valuation Metrics). 1 tied.
XAIR vs AVPT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is XAIR or AVPT a better buy right now?
For growth investors, Beyond Air, Inc.
(XAIR) is the stronger pick with 219. 7% revenue growth year-over-year, versus 26. 9% for AvePoint, Inc. (AVPT). AvePoint, Inc. (AVPT) offers the better valuation at 68. 8x trailing P/E (27. 7x forward), making it the more compelling value choice. Analysts rate AvePoint, Inc. (AVPT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — XAIR or AVPT?
Over the past 5 years, AvePoint, Inc.
(AVPT) delivered a total return of +1. 7%, compared to -99. 5% for Beyond Air, Inc. (XAIR). Over 10 years, the gap is even starker: AVPT returned +5. 5% versus XAIR's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — XAIR or AVPT?
By beta (market sensitivity over 5 years), Beyond Air, Inc.
(XAIR) is the lower-risk stock at 0. 47β versus AvePoint, Inc. 's 1. 06β — meaning AVPT is approximately 125% more volatile than XAIR relative to the S&P 500. On balance sheet safety, AvePoint, Inc. (AVPT) carries a lower debt/equity ratio of 2% versus 82% for Beyond Air, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — XAIR or AVPT?
By revenue growth (latest reported year), Beyond Air, Inc.
(XAIR) is pulling ahead at 219. 7% versus 26. 9% for AvePoint, Inc. (AVPT). On earnings-per-share growth, the picture is similar: AvePoint, Inc. grew EPS 193. 8% year-over-year, compared to 62. 1% for Beyond Air, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — XAIR or AVPT?
AvePoint, Inc.
(AVPT) is the more profitable company, earning 8. 4% net margin versus -1258. 4% for Beyond Air, Inc. — meaning it keeps 8. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVPT leads at 7. 9% versus -1202. 1% for XAIR. At the gross margin level — before operating expenses — AVPT leads at 74. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — XAIR or AVPT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is XAIR or AVPT better for a retirement portfolio?
For long-horizon retirement investors, Beyond Air, Inc.
(XAIR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 47)). Both have compounded well over 10 years (XAIR: -99. 6%, AVPT: +5. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between XAIR and AVPT?
These companies operate in different sectors (XAIR (Healthcare) and AVPT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.